Skip to Content

Cancers, Volume 10, Issue 4

2018 April - 42 articles

Cover Story: Anaplastic large cell lymphoma (ALCL) is a T-cell neoplasm with unique morphology and phenotype, which is subdivided into four different entities depending on clinical and molecular features: systemic ALK-positive ALCL, systemic ALK-negative ALCL, primary cutaneous ALCL, and breast implant-associated ALCL. While ALK fusion proteins are the genetic hallmark of ALK-positive ALCL and present a paradigm of a dominant oncogenic driver mutation, the genetic landscape of ALK-negative ALCL has only recently been explored further, deepening our understanding of its clinical behavior and pathogenesis and providing new targets to develop specific therapies. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (42)

  • Article
  • Open Access
29 Citations
10,274 Views
11 Pages

Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines

  • Ryohei Kozaki,
  • Meike Vogler,
  • Harriet S. Walter,
  • Sandrine Jayne,
  • David Dinsdale,
  • Reiner Siebert,
  • Martin J.S. Dyer and
  • Toshio Yoshizawa

23 April 2018

Bruton’s tyrosine kinase (BTK) is a key regulator of the B-cell receptor signaling pathway, and aberrant B-cell receptor (BCR) signaling has been implicated in the survival of malignant B-cells. However, responses of the diffuse large B-cell lymphoma...

  • Brief Report
  • Open Access
6 Citations
5,452 Views
13 Pages

Selective Inhibition of Histone Deacetylation in Melanoma Increases Targeted Gene Delivery by a Bacteriophage Viral Vector

  • Samuel Campbell,
  • Keittisak Suwan,
  • Sajee Waramit,
  • Eric Ofori Aboagye and
  • Amin Hajitou

21 April 2018

The previously developed adeno-associated virus/phage (AAVP) vector, a hybrid between M13 bacteriophage (phage) viruses that infect bacteria only and human Adeno-Associated Virus (AAV), is a promising tool in targeted gene therapy against cancer. AAV...

  • Article
  • Open Access
53 Citations
8,934 Views
15 Pages

Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress

  • Christophe Deben,
  • Vanessa Deschoolmeester,
  • Jorrit De Waele,
  • Julie Jacobs,
  • Jolien Van den Bossche,
  • An Wouters,
  • Marc Peeters,
  • Christian Rolfo,
  • Evelien Smits and
  • Patrick Pauwels
  • + 1 author

21 April 2018

The compound APR-246 (PRIMA-1MET) is a known reactivator of (mutant) p53 and inducer of oxidative stress which can sensitize cancer cells to platinum-based chemotherapeutics. However, the effect of a hypoxic tumor environment has been largely overloo...

  • Review
  • Open Access
46 Citations
8,459 Views
19 Pages

Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms

  • Shyambabu Chaurasiya,
  • Nanhai G. Chen and
  • Susanne G. Warner

19 April 2018

A growing body of evidence suggests that a subset of cells within tumors are resistant to conventional treatment modalities and may be responsible for disease recurrence. These cells are called cancer stem cells (CSC), which share properties with nor...

  • Review
  • Open Access
67 Citations
9,713 Views
29 Pages

Innovative Diagnostic Methods for Early Prostate Cancer Detection through Urine Analysis: A Review

  • Carmen Bax,
  • Gianluigi Taverna,
  • Lidia Eusebio,
  • Selena Sironi,
  • Fabio Grizzi,
  • Giorgio Guazzoni and
  • Laura Capelli

18 April 2018

Prostate cancer is the second most common cause of cancer death among men. It is an asymptomatic and slow growing tumour, which starts occurring in young men, but can be detected only around the age of 40–50. Although its long latency period an...

  • Perspective
  • Open Access
19 Citations
7,305 Views
5 Pages

Perspective: Contribution of Epstein–Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells

  • Chung-Chun Wu,
  • Chih-Yeu Fang,
  • Sheng-Yen Huang,
  • Shih-Hsin Chiu,
  • Chia-Huei Lee and
  • Jen-Yang Chen

17 April 2018

Nasopharyngeal carcinoma (NPC) is a squamous cell carcinoma derived from the epithelium of the post-nasal cavity, with a unique geographic and ethnic distribution. Epstein–Barr virus (EBV) is an etiological agent of NPC, but how it contributes...

  • Review
  • Open Access
21 Citations
6,812 Views
21 Pages

17 April 2018

The Hippo pathway serves as a key barrier for oncogenic transformation. It acts by limiting the activity of the proto-oncogenes YAP and TAZ. Reduced Hippo signaling and elevated YAP/TAZ activities are frequently observed in various types of tumors. E...

  • Feature Paper
  • Commentary
  • Open Access
11 Citations
6,943 Views
10 Pages

17 April 2018

The vertebrate body shape is formed by the specific sizes and shapes of its resident tissues and organs, whose alignments are essential for proper functioning. To maintain tissue and organ shape, and thereby function, it is necessary to remove senesc...

  • Article
  • Open Access
16 Citations
7,292 Views
14 Pages

NF-κB Signaling Regulates Epstein–Barr Virus BamHI-Q-Driven EBNA1 Expression

  • Rob J. A. Verhoeven,
  • Shuang Tong,
  • Jingfeng Zong,
  • Yixin Chen,
  • Sai-Wah Tsao,
  • Jianji Pan and
  • Honglin Chen

16 April 2018

Epstein–Barr virus (EBV) nuclear antigen 1 (EBNA1) is one of the few viral proteins expressed by EBV in nasopharyngeal carcinoma (NPC), most likely because of its essential role in maintaining the viral genome in EBV-infected cells. In NPC, EBNA1 exp...

  • Commentary
  • Open Access
157 Citations
14,324 Views
11 Pages

15 April 2018

Tumors and tumor-derived cell lines contain polyploid giant cells with significantly elevated genomic content, often with multiple nuclei. The frequency of giant cells can increase markedly following anticancer treatment. Although giant cells enter a...

  • Article
  • Open Access
20 Citations
6,083 Views
13 Pages

12 April 2018

Expenditure and financing aspects in the healthcare system in general, and in cancer care in particular, are subjects of increasing concern to the medical community. Nowadays, it is imperative for the healthcare system to respond to the challenge of...

  • Review
  • Open Access
12 Citations
7,914 Views
13 Pages

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma

  • Serena Stadler,
  • Vijay Kumar Singh,
  • Fabian Knörr,
  • Christine Damm-Welk and
  • Wilhelm Woessmann

10 April 2018

Patients with anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) mount a humoral and cellular immune response against ALK. More than 90% of children and adolescents with ALK-positive ALCL have detectable anti-ALK antibodi...

  • Feature Paper
  • Review
  • Open Access
130 Citations
14,593 Views
16 Pages

10 April 2018

Neuroblastoma (NB) is the most common and deadly solid tumour in children. Despite the development of new treatment options for high-risk NB, over half of patients relapse and five-year survival remains at 40–50%. Therefore, novel treatment strategie...

  • Feature Paper
  • Review
  • Open Access
143 Citations
17,155 Views
37 Pages

YAP/TAZ Activation as a Target for Treating Metastatic Cancer

  • Janine S. A. Warren,
  • Yuxuan Xiao and
  • John M. Lamar

10 April 2018

Yes-Associated Protein (YAP) and Transcriptional Co-activator with PDZ-binding Motif (TAZ) have both emerged as important drivers of cancer progression and metastasis. YAP and TAZ are often upregulated or nuclear localized in aggressive human cancers...

  • Article
  • Open Access
11 Citations
5,920 Views
15 Pages

Proton Beam Therapy Alone for Intermediate- or High-Risk Prostate Cancer: An Institutional Prospective Cohort Study

  • Takeshi Arimura,
  • Takashi Yoshiura,
  • Kyoko Matsukawa,
  • Naoaki Kondo,
  • Ikumi Kitano and
  • Takashi Ogino

10 April 2018

The role of proton beam therapy (PBT) as monotherapy for localized prostate cancer (PCa) remains unclear. The purpose of this study was to evaluate the efficacy and adverse events of PBT alone for these patients. Between January 2011 and July 2014, 2...

  • Article
  • Open Access
15 Citations
6,725 Views
17 Pages

9 April 2018

Acute Epstein-Barr virus (EBV) infection in immunosuppressed transplant patients can give rise to a malignant B-cell proliferation known as post-transplant lymphoproliferative disease (PTLD). The EBV major virion surface glycoprotein (gp)350 is a pri...

  • Review
  • Open Access
47 Citations
11,553 Views
24 Pages

New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update

  • Adrián Montaño,
  • Maribel Forero-Castro,
  • Darnel Marchena-Mendoza,
  • Rocío Benito and
  • Jesús María Hernández-Rivas

7 April 2018

The identification and study of genetic alterations involved in various signaling pathways associated with the pathogenesis of acute lymphoblastic leukemia (ALL) and the application of recent next-generation sequencing (NGS) in the identification of...

  • Article
  • Open Access
4 Citations
5,024 Views
10 Pages

Proton Partial Breast Irradiation: Detailed Description of Acute Clinico-Radiologic Effects

  • Valentina Ovalle,
  • Eric A. Strom,
  • Simona Shaitelman,
  • Karen Hoffman,
  • Richard Amos,
  • George Perkins,
  • Welela Tereffe,
  • Benjamin D. Smith,
  • Michael Stauder and
  • Wendy Woodward

7 April 2018

Introduction: Accelerated partial breast irradiation (APBI) with protons results in a very different acute effect profile than standard whole breast irradiation. We reviewed our initial experience with proton APBI and felt that a detailed description...

  • Review
  • Open Access
72 Citations
14,916 Views
30 Pages

6 April 2018

The presence of the Epstein-Barr virus (EBV)-encoded nuclear antigen-1 (EBNA1) protein in all EBV-carrying tumours constitutes a marker that distinguishes the virus-associated cancer cells from normal cells and thereby offers opportunities for target...

  • Review
  • Open Access
159 Citations
40,298 Views
23 Pages

Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site

  • Janick Selves,
  • Elodie Long-Mira,
  • Marie-Christine Mathieu,
  • Philippe Rochaix and
  • Marius Ilié

5 April 2018

Immunohistochemistry has become an essential ancillary examination for the identification and classification of carcinomas of unknown primary site (CUPs). Over the last decade, the diagnostic accuracy of organ- or tumour-specific immunomarkers and th...

  • Feature Paper
  • Review
  • Open Access
157 Citations
11,856 Views
15 Pages

4 April 2018

Gene rearrangements resulting in the aberrant activity of tyrosine kinases have been identified as drivers of oncogenesis in a variety of cancers. The tropomyosin receptor kinase (TRK) family of tyrosine receptor kinases is emerging as an important t...

  • Review
  • Open Access
62 Citations
6,994 Views
18 Pages

4 April 2018

Undifferentiated nasopharyngeal carcinoma (NPC) is strongly associated with Epstein-Barr virus (EBV) infection. In addition, heavy infiltration of leukocytes is a common characteristic of EBV-associated NPC. It has long been suggested that substantia...

  • Feature Paper
  • Review
  • Open Access
70 Citations
15,906 Views
22 Pages

The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)

  • Ivonne A. Montes-Mojarro,
  • Julia Steinhilber,
  • Irina Bonzheim,
  • Leticia Quintanilla-Martinez and
  • Falko Fend

4 April 2018

Anaplastic large cell lymphoma (ALCL) represents a group of malignant T-cell lymphoproliferations that share morphological and immunophenotypical features, namely strong CD30 expression and variable loss of T-cell markers, but differ in clinical pres...

  • Review
  • Open Access
24 Citations
7,495 Views
17 Pages

Role of Gene Therapy in Pancreatic Cancer—A Review

  • Mizuho Sato-Dahlman,
  • Keith Wirth and
  • Masato Yamamoto

3 April 2018

Mortality from pancreatic ductal adenocarcinoma (PDAC) has remained essentially unchanged for decades and its relative contribution to overall cancer death is projected to only increase in the coming years. Current treatment for PDAC includes aggress...

  • Review
  • Open Access
100 Citations
14,590 Views
18 Pages

The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies

  • Brianna M. Craver,
  • Kenza El Alaoui,
  • Robyn M. Scherber and
  • Angela G. Fleischman

3 April 2018

Hematopoietic stem cells (HSCs) maintain an organism’s immune system for a lifetime, and derangements in HSC proliferation and differentiation result in hematologic malignancies. Chronic inflammation plays a contributory if not causal role in HSC dys...

  • Review
  • Open Access
93 Citations
17,556 Views
14 Pages

1 April 2018

Bladder cancer is one of the most prevalent cancers worldwide. Unfortunately, there have been few advances in its clinical management due to a poor understanding of the correlations between its molecular and clinical features. Mounting evidence sugge...

  • Review
  • Open Access
362 Citations
10,406 Views
21 Pages

1 April 2018

Aberrant epigenetic modifications are an early event in carcinogenesis, with the epigenetic landscape continuing to change during tumor progression and metastasis—these observations suggest that specific epigenetic modifications could be used as diag...

  • Article
  • Open Access
58 Citations
7,507 Views
13 Pages

EBV+ and MSI Gastric Cancers Harbor High PD-L1/PD-1 Expression and High CD8+ Intratumoral Lymphocytes

  • Simona De Rosa,
  • Nora Sahnane,
  • Maria Grazia Tibiletti,
  • Francesca Magnoli,
  • Alessandro Vanoli,
  • Fausto Sessa and
  • Anna Maria Chiaravalli

1 April 2018

Both EBV+ and MSI gastric cancers (GCs) have high lymphoid infiltration which is rare in MSS/EBV cancers. PD-L1/PD-1 interaction leads to a down-regulated immune response and it is one of the most promising targets for gastric cancer immunotherapy....

  • Feature Paper
  • Review
  • Open Access
32 Citations
7,397 Views
11 Pages

30 March 2018

Nanopulse Stimulation (NPS) eliminates mouse and rat tumor types in several different animal models. NPS induces protective, vaccine-like effects after ablation of orthotopic rat N1-S1 hepatocellular carcinoma. Here we review some general concepts of...

  • Feature Paper
  • Review
  • Open Access
45 Citations
10,374 Views
25 Pages

30 March 2018

Epstein-Barr virus (EBV) is characterized by a bipartite life cycle in which latent and lytic stages are alternated. Latency is compatible with long-lasting persistency within the infected host, while lytic expression, preferentially found in orophar...

  • Feature Paper
  • Review
  • Open Access
82 Citations
14,794 Views
18 Pages

Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond

  • Nina Prokoph,
  • Hugo Larose,
  • Megan S. Lim,
  • G. A. Amos Burke and
  • Suzanne D. Turner

30 March 2018

Anaplastic Lymphoma Kinase (ALK)-positive Anaplastic Large Cell Lymphoma (ALCL), remains one of the most curable cancers in the paediatric setting; multi-agent chemotherapy cures approximately 65–90% of patients. Over the last two decades, major effo...

  • Article
  • Open Access
46 Citations
8,290 Views
19 Pages

Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer

  • Philipp Manegold,
  • Keane K. Y. Lai,
  • Yongfeng Wu,
  • Jia-Ling Teo,
  • Heinz-Josef Lenz,
  • Yuri S. Genyk,
  • Stephen J. Pandol,
  • Kaijin Wu,
  • David P. Lin and
  • Michael Kahn
  • + 3 authors

29 March 2018

Background: Although canonical Wnt signaling is known to promote tumorigenesis in pancreatic ductal adenocarcinoma (PDAC), a cancer driven principally by mutant K-Ras, the detailed molecular mechanisms by which the Wnt effector β-catenin regulates su...

  • Article
  • Open Access
11 Citations
5,454 Views
13 Pages

Dissecting the Mutational Landscape of Cutaneous Melanoma: An Omic Analysis Based on Patients from Greece

  • Georgia Kontogianni,
  • Georgia Piroti,
  • Ilias Maglogiannis,
  • Aristotelis Chatziioannou and
  • Olga Papadodima

29 March 2018

Melanoma is a lethal type of skin cancer, unless it is diagnosed early. Formalin-fixed, paraffin-embedded (FFPE) tissue is a valuable source for molecular assays after diagnostic examination, but isolated nucleic acids often suffer from degradation....

  • Feature Paper
  • Review
  • Open Access
125 Citations
15,881 Views
22 Pages

The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas

  • Ines Garces de los Fayos Alonso,
  • Huan-Chang Liang,
  • Suzanne D. Turner,
  • Sabine Lagger,
  • Olaf Merkel and
  • Lukas Kenner

28 March 2018

The Activator Protein-1 (AP-1) transcription factor (TF) family, composed of a variety of members including c-JUN, c-FOS and ATF, is involved in mediating many biological processes such as proliferation, differentiation and cell death. Since their di...

  • Review
  • Open Access
128 Citations
19,488 Views
20 Pages

The Hippo Pathway: Immunity and Cancer

  • Zaid Taha,
  • Helena J. Janse van Rensburg and
  • Xiaolong Yang

28 March 2018

Since its discovery, the Hippo pathway has emerged as a central signaling network in mammalian cells. Canonical signaling through the Hippo pathway core components (MST1/2, LATS1/2, YAP and TAZ) is important for development and tissue homeostasis whi...

  • Article
  • Open Access
7 Citations
4,217 Views
12 Pages

Loss of One or Two PATZ1 Alleles Has a Critical Role in the Progression of Thyroid Carcinomas Induced by the RET/PTC1 Oncogene

  • Mario Monaco,
  • Giuseppe Palma,
  • Michela Vitiello,
  • Anna Capiluongo,
  • Barbara D’Andrea,
  • Emilia Vuttariello,
  • Antonio Luciano,
  • Laura Cerchia,
  • Gennaro Chiappetta and
  • Monica Fedele
  • + 2 authors

27 March 2018

POZ/BTB and AT-hook-containing zinc finger protein 1 (PATZ1) is an emerging cancer-related gene that is downregulated in different human malignancies, including thyroid cancer, where its levels gradually decrease going from papillary thyroid carcinom...

  • Feature Paper
  • Review
  • Open Access
34 Citations
6,519 Views
19 Pages

Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives

  • Corina Cuceu,
  • William M. Hempel,
  • Laure Sabatier,
  • Jacques Bosq,
  • Patrice Carde and
  • Radhia M’kacher

26 March 2018

The study of Hodgkin lymphoma (HL), with its unique microenvironment and long-term follow-up, has provided exceptional insights into several areas of tumor biology. Findings in HL have not only improved our understanding of human carcinogenesis, but...

  • Feature Paper
  • Article
  • Open Access
23 Citations
6,242 Views
19 Pages

Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas

  • Octavia Ramayanti,
  • Mitch Brinkkemper,
  • Sandra A. W. M. Verkuijlen,
  • Leni Ritmaleni,
  • Mei Lin Go and
  • Jaap M. Middeldorp

22 March 2018

Epstein-Barr virus (EBV) persists in nasopharyngeal (NPC) and gastric carcinomas (EBVaGC) in a tightly latent form. Cytolytic virus activation (CLVA) therapy employs gemcitabine and valproic acid (GCb+VPA) to reactivate latent EBV into the lytic phas...

  • Feature Paper
  • Review
  • Open Access
42 Citations
9,471 Views
22 Pages

22 March 2018

Malignant mesothelioma (MM) constitutes a very aggressive tumor that arises from the pleural or peritoneal cavities and is highly refractory to conventional therapies. Several key genetic alterations are associated with the development and progressio...

  • Feature Paper
  • Review
  • Open Access
36 Citations
7,916 Views
22 Pages

New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma

  • Kathy H. Y. Shair,
  • Akhil Reddy and
  • Vaughn S. Cooper

21 March 2018

Latent membrane protein 1 (LMP1) is an Epstein-Barr virus (EBV) oncogenic protein that has no intrinsic enzymatic activity or sequence homology to cellular or viral proteins. The oncogenic potential of LMP1 has been ascribed to pleiotropic signaling...

  • Feature Paper
  • Article
  • Open Access
15 Citations
4,152 Views
22 Pages

Study of the Influence of NanOx Parameters

  • Caterina Monini,
  • Micaela Cunha,
  • Etienne Testa and
  • Michaёl Beuve

21 March 2018

NanOx is a new biophysical model that aims at predicting the biological effect of ions in the context of hadron therapy. It integrates the fully-stochastic nature of ionizing radiation both at micrometric and nanometric scales and also takes into acc...

  • Article
  • Open Access
15 Citations
6,243 Views
11 Pages

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients

  • Simon Heeke,
  • Véronique Hofman,
  • Elodie Long-Mira,
  • Virginie Lespinet,
  • Salomé Lalvée,
  • Olivier Bordone,
  • Camille Ribeyre,
  • Virginie Tanga,
  • Jonathan Benzaquen and
  • Paul Hofman
  • + 5 authors

21 March 2018

Background: With the integration of various targeted therapies into the clinical management of patients with advanced lung adenocarcinoma, next-generation sequencing (NGS) has become the technology of choice and has led to an increase in simultaneous...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694